Gail M Farfel is Chief Executive Officer of ProMIS Neurosciences Inc.. Currently has a direct ownership of 55,192 shares of PMN, which is worth approximately $63,470. The most recent transaction as insider was on Aug 23, 2023, when has been sold 53,192 shares (Common Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.2K
0% 3M change
0% 12M change
Total Value Held $63,470

Gail M Farfel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 23 2023
BUY
Grant, award, or other acquisition
-
53,192 Added 49.08%
55,192 Common Shares
Dec 14 2022
BUY
Open market or private purchase
$4,940 $4.94 p/Share
1,000 Added 33.33%
2,000 Common Shares
Dec 06 2022
BUY
Open market or private purchase
$5,700 $5.7 p/Share
1,000 Added 50.0%
1,000 Common Share

Also insider at

AVRO
AVROBIO, Inc. Healthcare
ZGNX
ZOGENIX, INC.
DRRX
DURECT CORP Healthcare
GMF

Gail M Farfel

Chief Executive Officer
Toronto, A6

Track Institutional and Insider Activities on PMN

Follow ProMIS Neurosciences Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PMN shares.

Notify only if

Insider Trading

Get notified when an Pro Mis Neurosciences Inc. insider buys or sells PMN shares.

Notify only if

News

Receive news related to ProMIS Neurosciences Inc.

Track Activities on PMN